Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Board/Management Information 2024

Mar 8, 2024

5262_mang_2024-03-08_67abf191-688c-40f4-89cc-de525240996f.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2295G

GSK PLC

08 March 2024

GSK plc

Board Committee Change

GSK plc today announces the following change to its Board Committee membership with effect from 11 March 2024:

Dr Hal Dietz has been appointed a member of the Nominations & Corporate Governance Committee. This appointment is in addition to his role as Chair of the Science Committee and membership of the Chairs' Committee.

V A Whyte

Company Secretary

8 March 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAEAXDPEFELEFA